The GEF‐H1/PKD3 signaling pathway promotes the maintenance of triple‐negative breast cancer stem cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The GEF‐H1/PKD3 signaling pathway promotes the maintenance of triple‐negative breast cancer stem cells

Published:2019-12-14 Issue:12 Volume:146 Page:3423-3434
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Lieb Wolfgang S.¹,Lungu Cristiana¹,Tamas Raluca¹,Berreth Hannah¹,Rathert Philipp²,Storz Peter³,Olayioye Monilola A.¹^ORCID,Hausser Angelika¹^ORCID

Affiliation:

1. Institute of Cell Biology and Immunology and Stuttgart Research Center Systems Biology University of Stuttgart Stuttgart Germany

2. Biochemistry Department Institute of Biochemistry and Technical Biochemistry, University of Stuttgart Stuttgart Germany

3. Department of Cancer Biology Mayo Clinic Jacksonville FL

Funder

Deutsche Krebshilfe

National Institutes of Health

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.32798

Reference51 articles.

1. Molecular portraits of human breast tumours

2. Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer

3. Subtypes of Breast Cancer Show Preferential Site of Relapse

4. Triple-Negative Breast Cancer

5. Neoadjuvant carboplatin in patients with triple-negative and HER2-positive early breast cancer (GeparSixto; GBG 66): a randomised phase 2 trial

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Protein kinase D drives the secretion of invasion mediators in triple-negative breast cancer cell lines;iScience;2024-02

2. Advancements in the Research of GEF-H1: Biological Functions and Tumor Associations;Current Molecular Pharmacology;2024-01-30

3. Membrane trafficking in breast cancer progression: protein kinase D comes into play;Frontiers in Cell and Developmental Biology;2023-05-24

4. Small Molecule Inhibitors of Protein Kinase D: Early Development, Current Approaches, and Future Directions;Journal of Medicinal Chemistry;2022-12-20

5. Androgen deprivation restores ARHGEF2 to promote neuroendocrine differentiation of prostate cancer;Cell Death & Disease;2022-11-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3